Literature DB >> 2887193

A system for transformation of rat liver cells in vitro by acute treatment with aflatoxin.

S Sinha, L J Hockin, G E Neal.   

Abstract

Aflatoxin B1 (AFB1) induced rat liver cancer is a well studied system of hepatocarcinogenesis. AFB1 has also been used to transform cultured rat liver derived cells in vitro. Cells in culture often have a reduced capacity to metabolise the AFB1 to its active metabolite, and often prolonged periods of exposure to the toxin have to be employed, with a long latency in the appearance of transformed cells in culture. We report here the transformation of a rat liver derived cell line by acute treatment with AFB1. An extrinsic metabolising system of quail microsomes, which convert AFB1 to its epoxide form with high efficiency, was used to activate the AFB1. A dose dependent cytotoxicity was obtained and neoplastic transformation was seen in the higher doses used. The enzyme GGT which has strong association with liver cell transformation both in vivo and in vitro was also elevated in the treated cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2887193      PMCID: PMC2002029          DOI: 10.1038/bjc.1987.121

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

Review 1.  The role of aflatoxin metabolism in its toxic lesion.

Authors:  T C Campbell; J R Hayes
Journal:  Toxicol Appl Pharmacol       Date:  1976-02       Impact factor: 4.219

2.  Histochemistry of gamma-glutamyl transpeptidase in rat liver during aflatoxin B1-induced carcinogenesis.

Authors:  M M Kalengayi; G Ronchi; V J Desmet
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

3.  The in vitro metabolism of aflatoxin B1 catalyzed by hepatic microsomes isolated from control or 3-methylcholanthrene-stimulated rats and quail.

Authors:  G E Neal; D J Judah; J A Green
Journal:  Toxicol Appl Pharmacol       Date:  1986-03-15       Impact factor: 4.219

4.  Animal model of human disease: primary hepatocellular carcinoma.

Authors:  P M Newberne; A E Rogers
Journal:  Am J Pathol       Date:  1973-07       Impact factor: 4.307

5.  Cell cycle dependence of chemically induced malignant transformation in vitro.

Authors:  H Marquardt
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

6.  Neoplastic transformation of human diploid cells in vitro after chemical carcinogen treatment.

Authors:  G E Milo; J A DiPaolo
Journal:  Nature       Date:  1978-09-14       Impact factor: 49.962

7.  Drug metabolism in adult rat hepatocytes in primary monolayer culture.

Authors:  P S Guzelian; D M Bissell; U A Meyer
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

8.  A sensitive fluorimetric assay for gamma-glutamyl transferase.

Authors:  G D Smith; J L Ding; T J Peters
Journal:  Anal Biochem       Date:  1979-11-15       Impact factor: 3.365

9.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

10.  Malignant transformation in vitro of rat liver cells by dimethylnitrosamine and N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  R Montesano; L Saint Vincent; L Tomatis
Journal:  Br J Cancer       Date:  1973-09       Impact factor: 7.640

View more
  3 in total

1.  Sensitivity of the cell cycle to TGF beta 1 does not correlate with transformation of a rat liver epithelial cell line.

Authors:  R Davies; R F Legg; G E Neal
Journal:  Cell Biol Toxicol       Date:  1990-10       Impact factor: 6.691

2.  Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis.

Authors:  S Sinha; C Webber; C J Marshall; M A Knowles; A Proctor; N C Barrass; G E Neal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

3.  The expression of c-myc related to the proliferation and transformation of rat liver-derived epithelial cells.

Authors:  S Sinha; G E Neal; R F Legg; J V Watson; C Pearson
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.